Synthesis and antitumor activity of α,β-unsaturated carbonyl moiety-containing oleanolic acid derivatives targeting PI3K/AKT/mTOR signaling pathway

被引:24
|
作者
Wang, Shi-Sheng [1 ]
Zhang, Qiao-Li [1 ]
Chu, Peng [2 ]
Kong, Ling-Qi [1 ]
Li, Guang-Zhe [1 ]
Li, Yue-Qing [1 ]
Yang, Li [1 ]
Zhao, Wei-Jie [1 ]
Guo, Xiu-Han [1 ]
Tang, Ze-Yao [2 ]
机构
[1] Dalian Univ Technol, Sch Chem Engn, Dept Pharm, Dalian 116024, Peoples R China
[2] Dalian Med Univ, Dept Pharmacol, Dalian 116044, Peoples R China
基金
中国国家自然科学基金;
关键词
Oleanolic acid derivatives; Anticancer; PI3K/AKT/mTOR signaling pathway; Cell apoptosis induction; S phase arrest; ROS-DEPENDENT APOPTOSIS; NITRIC-OXIDE PRODUCTION; BARDOXOLONE METHYL; CANCER CELLS; URSANE TRITERPENOIDS; AUTOPHAGY; OLEANANE; INHIBITORS; INDUCTION; DESIGN;
D O I
10.1016/j.bioorg.2020.104036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oleanolic acid (OA) and its semi-synthetic derivatives have been reported to have a wide range of biological activities. The introduction of electrophilic Michael acceptor group can increase the reactivity of OA to cellular targets and thus improve the anti-tumor activity. In this work, a series of novel alpha,beta-unsaturated carbonyl de-rivatives of OA were designed and synthesized. Their in vitro cytotoxic activity against MCF-7, HepG2 and HeLa cells were tested. Most derivatives exhibited improved cell growth inhibitory activity, especially for 3d with an IC50 of 0.77 mu M in MCF-7 cells. Moreover, 3d inhibited the migration of MCF-7 and HeLa cells at the con-centration of 4 mu M. Flow cytometric analysis revealed that 3d induced cell apoptosis and S phase arrest in a concentration-dependent manner. Western blotting experiment demonstrated that 3d inhibited the phosphor-ylation of AKT and mTOR. These results suggest that this series of OA derivatives bearing exocyclic methylene ketone pharmacophore are promising anticancer agents as potential PI3K/AKT/mTOR pathway inhibitors.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] The PI3K/AKT/mTOR Signaling Pathway Is Overactivated in Primary Aldosteronism
    Su, Hengchuan
    Gu, Yanyun
    Li, Fengying
    Wang, Qidi
    Huang, Baoxing
    Jin, Xiaolong
    Ning, Guang
    Sun, Fukang
    PLOS ONE, 2013, 8 (04):
  • [42] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [43] Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting
    Qiang, Min
    Chen, Zhe
    Liu, Hongyang
    Dong, Junxue
    Gong, Kejian
    Zhang, Xinjun
    Huo, Peng
    Zhu, Jingjun
    Shao, Yifeng
    Ma, Jinazun
    Zhang, Bowei
    Liu, Wei
    Tang, Mingbo
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [44] Synthesis and discovery of mitochondria-targeting oleanolic acid derivatives for potential PI3K inhibition
    Li, Yi
    Zeng, Qingqing
    Wang, Rui
    Wang, Bo
    Chen, Ruofan
    Wang, Na
    Lu, Yiru
    Shi, Fangwen
    Dehaen, Wim
    Huai, Qiyong
    FITOTERAPIA, 2022, 162
  • [45] Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas
    Su, Yu-Chieh
    Lee, Wei-Chang
    Wang, Chih-Chun
    Yeh, Shyh-An
    Chen, Wen-Hui
    Chen, Po-Jen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [46] Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects
    Stanciu, Silviu
    Ionita-Radu, Florentina
    Stefani, Constantin
    Miricescu, Daniela
    Stanescu-Spinu, Iulia-Ioana
    Greabu, Maria
    Totan, Alexandra Ripszky
    Jinga, Mariana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [47] PI3K/AKT/MTOR SIGNALING PATHWAY ACTIVITY IN IDH-MUTANT DIFFUSE GLIOMA
    Mohamed, Esraa
    Kumar, Anupam
    Hilz, Stephanie
    Wang, Albert
    Shai, Anny
    Taylor, Jennie
    Clarke, Jennifer
    Molinaro, Annette
    Lee, Julieann
    Costello, Joseph
    Solomon, David
    Phillips, Joanna
    NEURO-ONCOLOGY, 2020, 22 : 9 - 10
  • [48] Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression
    Yu, Dandan
    Zhang, Yong
    Chen, Gege
    Xie, Yongsheng
    Xu, Zhijian
    Chang, Shuaikang
    Hu, Liangning
    Li, Bo
    Bu, Wenxuan
    Wang, Yingcong
    Xiao, Wenqin
    Sun, Xi
    Chang, Gaomei
    Gao, Lu
    Qiang, Sujing
    Wu, Xiaosong
    Zhu, Weiliang
    Shi, Jumei
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2018, 50 (08) : 782 - 792
  • [49] Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding
    Sami, Arshawn
    Karsy, Michael
    TUMOR BIOLOGY, 2013, 34 (04) : 1991 - 2002
  • [50] Anticancer Drug Discovery from Natural Compounds Targeting PI3K/AKT/mTOR Signaling Pathway
    da Silva, Manuele Figueiredo
    Lins, Arestides Alves
    Gomes, Midiane Correia
    Marinho, Washley Phyama de Jesus
    de Araujo, Rodrigo Santos Aquino
    de Moura, Ricardo Olimpio
    Zhan, Peng
    Nascimento, Igor Jose dos Santos
    da Silva, Edeildo Ferreira
    CURRENT MEDICINAL CHEMISTRY, 2024,